Liver cancer is a common malignant tumor of the digestive tract. This article highlights the common treatments for liver cancer to patients: 1. Liver transplantation: Liver transplantation is a surgical procedure to remove the liver that has lost its function and replace it with a healthy liver when the liver disease has progressed to a life-threatening stage. It treats primary liver cancer, liver cancer combined with cirrhosis; fulminant liver failure; malignant liver disease; it is one of the treatment options for early stage liver cancer patients. 2.Surgical resection: surgical resection is the first choice in liver cancer treatment, but the key to achieve satisfactory curative effect is early diagnosis. However, the key to achieve satisfactory curative effect is early diagnosis. Surgical resection of early stage liver cancer can achieve better curative effect. For other stages of hepatocellular carcinoma, the efficacy of surgery is comparable to ablation or intervention, but it is more damaging to patients. 3.Local ablation: It is mainly used for the treatment of early and middle stage liver cancer. It can also be used for ultra early stage liver cancer that is not suitable for surgery or patients are unwilling to undergo surgery, such as tumor location (e.g. near large blood vessels), and it can also be used to reduce the load of late stage liver cancer. Local ablation can be performed by percutaneously puncturing the ablation needle to the appropriate location of the tumor to achieve necrosis of the tumor through different physicochemical means, which is less harmful to the body. At present, it is mainly divided into thermal ablation (radiofrequency, microwave), cold ablation (argon helium knife) and anhydrous alcohol injection, which are purely physical means without the toxic side effects of chemotherapy and radiotherapy. (1) Thermal ablation (radiofrequency, microwave) mainly achieves the purpose of killing tumor through super high temperature. (2) Cold ablation (Ar-He knife) mainly causes necrosis and disintegration of tumor cells through ultra-low temperature. (3) Anhydrous alcohol injection: it kills tumor by injecting anhydrous alcohol into the tumor, which is usually used in conjunction with cold and hot ablation. 4.Interventional therapy: In fact, in a broad sense, local ablation is also a kind of interventional therapy, but the current interventional therapy usually refers to hepatic artery chemoembolization therapy (TACE), which is mainly used for the treatment of middle and late stage liver cancer. 5.Particle implantation therapy: Iodine particles with radioactive effect are implanted into the tumor lesion to destroy the tumor tissue, which is a relatively less invasive and effective palliative radiotherapy means. 6.Molecular targeted therapy drug: Molecular targeted therapy drug is an anti-tumor drug used in recent years. At present, only one drug, Doxorubicin (generic name: sorafenib mesylate), has been approved by FDA and SFDA of China for the treatment of distant metastasis or liver cancer that cannot be removed surgically, mainly used for the treatment of intermediate and advanced liver cancer, which can effectively prolong the median survival. 7.Chinese medicine: Chinese medicine, as a unique treatment means in China, has achieved better efficacy in many liver cancer patients. It adopts the method of discriminative treatment, attacking and supplementing at the same time, and is often applied in combination with other therapies. It is often applied together with other therapies to improve the body’s resistance to disease, improve the general condition and symptoms, and reduce the adverse effects of chemotherapy and radiotherapy. 8.General radiotherapy: liver cancer is usually not sensitive to radiotherapy, however, some new technologies such as Hepatome and radioactive knife have also shown better efficacy. Radiotherapy is usually used for the treatment of middle and late stage liver cancer. 9.Cellular biotherapy: mainly refers to CIK and other immune cell infusion, which is mainly used for the treatment of advanced liver cancer and is mainly in clinical trial stage at present.